Primary biliary cholangitis – Basic Information

Go back

Primary biliary cholangitis is a long-term liver condition that slowly damages the small tubes in the liver that carry bile, a digestive fluid essential for breaking down fats. When these bile ducts become inflamed and eventually destroyed, bile builds up inside the liver, causing tissue damage that can gradually lead to scarring. This progressive condition affects mostly women and develops slowly over many years, though with early treatment and lifestyle changes, many people can manage the disease and maintain their quality of life.

How Common is Primary Biliary Cholangitis

Primary biliary cholangitis is a relatively uncommon condition that affects a specific segment of the population more than others. Research from 2014 estimated that approximately 58 out of every 100,000 women in the United States have this disease, while only about 15 out of every 100,000 men are affected.[5] This means women are significantly more likely to develop the condition than men, with some sources reporting a ratio as high as 10 to 1.[2]

The condition typically appears in middle age, with most people receiving their diagnosis around age 60.[5] However, this doesn’t mean younger individuals are completely exempt, as the disease can occasionally affect younger women as well. Geographically, certain populations show higher rates of primary biliary cholangitis. People living in Scotland, Scandinavia, and Northeast England experience more cases of this condition compared to other regions.[2]

When looking at global estimates, the prevalence ranges quite widely, from 19 to 402 cases per million individuals depending on the population studied.[7] This variation might reflect differences in diagnosis rates, genetic factors, or environmental exposures across different geographic areas. Understanding who gets affected most helps doctors identify at-risk individuals earlier and begin monitoring or treatment before significant liver damage occurs.

What Causes Primary Biliary Cholangitis

Primary biliary cholangitis is believed to be an autoimmune disease, which means the body’s defense system mistakenly attacks its own healthy tissues instead of protecting against harmful invaders like bacteria or viruses.[1] In this case, the immune system targets and damages the small bile ducts within the liver, causing inflammation that gradually destroys these essential passageways.

The exact trigger that causes the immune system to malfunction in this way remains unclear to researchers. However, scientists believe that a combination of genetic makeup and environmental factors work together to set off this inappropriate immune response.[1] This means that some people may be born with genes that make them more susceptible, but something in their environment might act as the final trigger that starts the disease process.

Several environmental factors have been studied as possible triggers, including urinary tract infections, the use of reproductive hormone replacement therapy, exposure to nail polish, and cigarette smoking.[7] While exposure to certain bacteria, viruses, or toxins is thought to potentially trigger the immune system reaction, researchers haven’t pinpointed one specific cause that applies to everyone with the condition.[16]

⚠️ Important
Primary biliary cholangitis is not contagious and cannot be spread from person to person. It develops from within the body when the immune system begins attacking the liver’s bile ducts. Although the exact cause isn’t fully understood, having a family member with the condition increases your risk, suggesting genetics play an important role.

Who is at Higher Risk

Certain groups of people face a higher likelihood of developing primary biliary cholangitis based on several factors. Women are overwhelmingly more affected than men, representing approximately 90 percent of all diagnosed cases.[8] This striking gender difference suggests that hormones or other biological factors related to being female might play a protective or triggering role, though the exact mechanism isn’t fully understood.

Age represents another significant risk factor. Most people receive their diagnosis after reaching age 40, with the average age at diagnosis being 60 years old.[5] While the condition can develop in younger individuals, it becomes increasingly common as people enter their middle and later years.

Family history strongly influences risk as well. People who have a parent or sibling with primary biliary cholangitis face higher chances of developing the condition themselves, and the risk is even greater for identical twins.[5] This familial clustering suggests that inherited genetic factors contribute significantly to disease susceptibility, even though specific genes haven’t been definitively identified as causes.

Race and ethnicity also affect risk patterns. White individuals develop primary biliary cholangitis more frequently than people from other racial or ethnic backgrounds.[5] Additionally, having another autoimmune condition substantially increases risk. People with autoimmune diseases such as thyroid disorders, Raynaud’s disease (where fingers and toes become very sensitive to cold), Sjögren’s syndrome (causing dry eyes and mouth), scleroderma (skin and connective tissue hardening), or autoimmune hepatitis are more likely to also develop primary biliary cholangitis.[5] Celiac disease and systemic sclerosis particularly raise the risk.[7]

Recognizing the Symptoms

Many people with primary biliary cholangitis experience no noticeable symptoms when they first receive their diagnosis. In fact, more than half of individuals learn they have the condition only after routine blood tests reveal abnormal liver function, often performed for completely unrelated reasons.[1] This silent beginning makes the disease particularly challenging to detect without medical testing.

When symptoms do appear, they typically develop gradually as the disease progresses. The two most common and earliest symptoms are extreme tiredness, experienced by about 65 percent of patients, and itchy skin, affecting approximately 55 percent.[2] The fatigue associated with this condition differs from ordinary tiredness. It doesn’t improve with rest or a good night’s sleep, and it can significantly interfere with daily activities and quality of life.[13]

The itching, also called pruritus, feels different from surface skin irritation. Many patients describe it as a burning sensation that seems to come from under the skin rather than on top of it.[21] Scratching doesn’t provide relief and actually tends to make the feeling worse. This type of itching can be intense enough to disrupt sleep and normal activities.

Other symptoms that may develop include dry eyes and dry mouth, which can make eating, speaking, and wearing contact lenses uncomfortable.[1] Some people experience bone and joint aches or pain and discomfort in the upper right side of their abdomen, where the liver is located.[6] Interestingly, the severity of symptoms doesn’t always correlate with how advanced the disease has become. Some people with early-stage disease may have severe itching and fatigue, while others with more progressed disease might have minimal symptoms.[2]

As the condition advances and liver damage becomes more severe, additional complications may appear. These include jaundice, which causes yellowing or discoloration of the skin and the whites of the eyes due to bile buildup.[6] Women with primary biliary cholangitis may also develop frequent urinary tract infections.[5]

Prevention and Early Detection

Because primary biliary cholangitis is an autoimmune condition with unclear triggers, there’s no guaranteed way to prevent it from developing. However, certain lifestyle choices and health practices may help reduce risk factors or detect the disease early when treatment can be most effective.

Regular health check-ups that include routine blood work can lead to early detection of the disease, even before symptoms appear. Since many people discover they have primary biliary cholangitis through routine liver function tests ordered for other reasons, maintaining a relationship with a healthcare provider and following through with recommended screenings becomes important, especially for those at higher risk.[1]

For individuals who already have one autoimmune disease, staying vigilant about new symptoms and maintaining regular medical follow-up becomes particularly important. Since having one autoimmune condition increases the risk of developing others, including primary biliary cholangitis, these individuals benefit from periodic liver function monitoring.[5]

Avoiding potential environmental triggers may help reduce risk, though research in this area remains incomplete. Some studies have suggested associations between the disease and factors like urinary tract infections, hormone replacement therapy, nail polish exposure, and cigarette smoking.[7] While definitive proof that avoiding these factors prevents the disease is lacking, maintaining overall health through not smoking and treating infections promptly supports general wellness.

For people already diagnosed with primary biliary cholangitis, prevention shifts focus to stopping or slowing disease progression. Early treatment with prescribed medications can help delay liver damage.[1] Following a healthy lifestyle that includes proper nutrition, regular exercise, avoiding alcohol or limiting intake as recommended by doctors, and not smoking all contribute to maintaining liver health and preventing complications.[13]

Understanding What Happens in the Body

To understand primary biliary cholangitis, it helps to know what bile ducts do and why their damage causes problems. The liver produces bile, a yellowish-green fluid that serves multiple critical functions in the body. Bile helps digest fats from food, absorb fat-soluble vitamins like A, D, E, and K, and eliminate waste products including cholesterol, toxins, and worn-out red blood cells.[1]

Small tubes called bile ducts run throughout the liver, collecting bile and transporting it to the gallbladder for storage and eventually to the small intestine where it aids digestion.[8] In primary biliary cholangitis, the immune system attacks these small bile ducts specifically within the liver, causing them to become inflamed. The term “cholangitis” literally means inflammation of the bile ducts, while “primary” indicates that the inflammation isn’t caused by another condition like an infection or blockage—the disease itself is the original cause.[2]

This chronic inflammation gradually damages and destroys the bile ducts over time. While temporary inflammation can be part of normal healing, constant inflammation leads to excessive scarring. As the ducts become scarred, they narrow and become distorted, which blocks the normal flow of bile.[2] When bile cannot flow through the damaged ducts, it backs up and accumulates in the liver tissue itself.

The buildup of bile causes further inflammation and damage to liver cells. Over months and years, this ongoing injury leads to fibrosis, where excess connective tissue forms in response to the damage.[8] If this process continues unchecked, the liver develops extensive scarring throughout its structure, a condition called cirrhosis. In cirrhosis, scar tissue gradually replaces healthy, functioning liver tissue, and the liver loses its ability to perform its essential tasks.[2]

The disease progresses slowly through several stages, typically taking decades in many cases. The rate of progression varies significantly from person to person—some individuals may see their disease advance faster than others.[8] Without treatment, the ongoing damage can eventually lead to liver failure, where the liver can no longer function adequately to sustain life.[2]

Primary biliary cholangitis also affects the body beyond the liver. The reduced ability to absorb fat-soluble vitamins can lead to deficiencies in vitamins A, D, E, and K.[5] Vitamin D deficiency combined with other factors can contribute to osteoporosis, a condition where bones become weak and brittle, occurring in about 30 percent of people with the condition.[18] Many people develop abnormally high blood cholesterol levels, though interestingly, this doesn’t seem to increase heart disease risk in the same way it does in the general population.[5]

⚠️ Important
The name of this condition was changed from “primary biliary cirrhosis” to “primary biliary cholangitis” because the old name was misleading. Most people with this disease do not have cirrhosis when diagnosed, and with proper treatment, many never develop it. The new name better reflects that inflammation of the bile ducts is the primary problem, and cirrhosis is a potential later complication rather than an inevitable outcome.

Ongoing Clinical Trials on Primary biliary cholangitis

  • Study on Bezafibrate for Patients with Primary Biliary Cholangitis Not Responding Well to Ursodeoxycholic Acid

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia Denmark France Greece +8
  • Study on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Greece Hungary Italy Spain
  • Study on the Safety and Effectiveness of Saroglitazar Magnesium for Patients with Primary Biliary Cholangitis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Iceland
  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Croatia Czechia Estonia France Germany +6
  • Study on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis

    Not recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +3

References

https://www.mayoclinic.org/diseases-conditions/primary-biliary-cholangitis/symptoms-causes/syc-20376874

https://my.clevelandclinic.org/health/diseases/17715-primary-biliary-cholangitis-pbc

https://liverfoundation.org/liver-diseases/autoimmune-liver-diseases/primary-biliary-cholangitis-pbc/

https://gi.org/topics/primary-biliary-cirrhosis-pbc/

https://www.niddk.nih.gov/health-information/liver-disease/primary-biliary-cholangitis/definition-facts

https://www.nhs.uk/conditions/primary-biliary-cholangitis-pbc/

https://arupconsult.com/content/primary-biliary-cirrhosis

https://www.interceptpharma.com/our-focus/pbc/

https://britishlivertrust.org.uk/information-and-support/liver-conditions/primary-biliary-cholangitis/

https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.primary-biliary-cholangitis-pbc.aa89995spec

https://www.mayoclinic.org/diseases-conditions/primary-biliary-cholangitis/diagnosis-treatment/drc-20376880

https://my.clevelandclinic.org/health/diseases/17715-primary-biliary-cholangitis-pbc

https://www.nhs.uk/conditions/primary-biliary-cholangitis-pbc/treatment/

https://www.niddk.nih.gov/health-information/liver-disease/primary-biliary-cholangitis/treatment

https://emedicine.medscape.com/article/171117-treatment

https://www.uchicagomedicine.org/conditions-services/liver-diseases-hepatology/primary-biliary-cholangitis-pbc

https://www.mypbcteam.com/resources/living-with-pbc-tips-for-managing-symptoms

https://health.clevelandclinic.org/living-with-pbc

https://britishlivertrust.org.uk/information-and-support/liver-conditions/primary-biliary-cholangitis/living-with-pbc/

https://liverfoundation.org/resource-center/blog/patients-speak-out-about-living-with-pbc/

https://www.antidote.me/blog/living-with-pbc

https://www.realpbctalk.com/about-pbc

https://www.livingwithpbc.com/life-with-pbc/

FAQ

Can primary biliary cholangitis be cured?

Currently, there is no cure for primary biliary cholangitis. However, medications can help slow the progression of liver damage, especially when treatment begins early. With proper management, many people live for years with the disease while maintaining their quality of life.

How is primary biliary cholangitis diagnosed?

Diagnosis typically starts with blood tests that check liver enzyme levels, particularly alkaline phosphatase, and test for antimitochondrial antibodies, which are present in more than 90 percent of people with PBC. Many people discover they have the condition through routine blood work done for other reasons. Additional tests like ultrasound or sometimes a liver biopsy may be performed to confirm the diagnosis.

Will I need a liver transplant if I have PBC?

Not everyone with primary biliary cholangitis will need a liver transplant. The disease progresses slowly, and with early treatment using medications like ursodeoxycholic acid, many people can slow liver damage significantly. Liver transplantation becomes necessary only in cases where the disease has progressed to liver failure despite treatment, which doesn’t happen to all patients.

Can I still have children if I have primary biliary cholangitis?

Yes, women with primary biliary cholangitis can become pregnant and have babies. However, it’s important to discuss pregnancy plans with your doctor beforehand, as some medications used to treat PBC may need to be adjusted during pregnancy, and you’ll need careful monitoring throughout.

What can I do about the extreme itching?

Itching from PBC can be managed in several ways. Doctors often prescribe medications like cholestyramine specifically for itch relief. Many patients find that avoiding heat triggers, taking cool baths, using soft brushes instead of scratching, and keeping skin moisturized can help. If standard treatments don’t work, alternative medications like rifampicin or naltrexone may be options to discuss with your specialist.

🎯 Key Takeaways

  • Primary biliary cholangitis affects 9 out of 10 patients who are women, typically diagnosed around age 60, though younger people can also develop it
  • More than half of people have no symptoms when diagnosed, discovering the condition only through routine blood tests
  • The immune system mistakenly attacks bile ducts in the liver, causing bile to back up and gradually damage liver tissue
  • Having another autoimmune disease like thyroid disorders or Sjögren’s syndrome significantly increases your risk of developing PBC
  • The two most common symptoms—fatigue and itchy skin—can appear at any stage and don’t necessarily indicate how advanced the disease is
  • Early treatment with medications can slow disease progression and help many people avoid severe complications like cirrhosis
  • The condition was renamed from “primary biliary cirrhosis” because most people don’t have cirrhosis at diagnosis
  • Regular monitoring with blood tests every 3-6 months and ultrasounds help track disease progression and treatment response